Clinical Trial Transparency & Disclosure

How to Design Journal Policies & Preprints That Meets FDA, EMA and MHRA Expectations How to Design Journal Policies & Preprints That Meets FDA, EMA and MHRA Expectations Designing journal policies and preprints that align with regulatory standards is crucial for ensuring the transparency of clinical research administration processes. Regulatory agencies such as the FDA,…

Read More “How to Design Journal Policies & Preprints That Meets FDA, EMA and MHRA Expectations” »

Aligning Journal Policies & Preprints With ICH, GCP and Transparency Regulations Aligning Journal Policies & Preprints With ICH, GCP and Transparency Regulations The integration of ICH-GCP principles in clinical trial research has become increasingly important as the field advances towards greater transparency and accountability. This is particularly relevant for clinical trial researchers who are tasked…

Read More “Aligning Journal Policies & Preprints With ICH, GCP and Transparency Regulations” »

Common Pitfalls in Journal Policies & Preprints—and How to Avoid Costly Findings Common Pitfalls in Journal Policies & Preprints—and How to Avoid Costly Findings Introduction to Journal Policies and Preprints In the field of clinical research, strict adherence to journal policies and the regulatory framework governing preprints is essential. Understanding the nuances of these policies…

Read More “Common Pitfalls in Journal Policies & Preprints—and How to Avoid Costly Findings” »

Digital Tools and Automation to Streamline Journal Policies & Preprints In today’s clinical research landscape, transparency and efficient communication of study results have become paramount. The integration of digital tools and automation in managing journal policies and preprints can significantly enhance compliance and accessibility of findings. This article outlines a comprehensive step-by-step guide on how…

Read More “Digital Tools and Automation to Streamline Journal Policies & Preprints” »

Journal Policies & Preprints Playbook for High-Profile and Late-Phase Trials Journal Policies & Preprints Playbook for High-Profile and Late-Phase Trials In the rapidly evolving landscape of clinical research, transparency and timely dissemination of findings have become paramount. This step-by-step tutorial aims to provide clinical operations, regulatory affairs, and medical affairs professionals in the US, UK,…

Read More “Journal Policies & Preprints Playbook for High-Profile and Late-Phase Trials” »

KRIs, KPIs and Dashboards to Monitor Journal Policies & Preprints Across Portfolios KRIs, KPIs and Dashboards to Monitor Journal Policies & Preprints Across Portfolios In the ever-evolving landscape of clinical research, the need for transparency and compliance has never been more crucial. With the increasing complexity of clinical research trials and the imperative nature of…

Read More “KRIs, KPIs and Dashboards to Monitor Journal Policies & Preprints Across Portfolios” »

Inspection and Audit Readiness: Documenting Journal Policies & Preprints for Regulators Inspection and Audit Readiness: Documenting Journal Policies & Preprints for Regulators Clinical trials represent a critical pathway for the development of innovative therapies. However, with the rigorous regulatory frameworks established by organizations such as the FDA, EMA, and MHRA, it is essential for clinical…

Read More “Inspection and Audit Readiness: Documenting Journal Policies & Preprints for Regulators” »

Integrating Journal Policies & Preprints With Data Privacy, GDPR and HIPAA Requirements The integration of journal policies and preprints with data privacy frameworks, particularly the General Data Protection Regulation (GDPR) and the Health Insurance Portability and Accountability Act (HIPAA), presents intricate challenges and opportunities in the realm of translational clinical research. This guide provides a…

Read More “Integrating Journal Policies & Preprints With Data Privacy, GDPR and HIPAA Requirements” »

Case Studies: Journal Policies & Preprints That Strengthened Public and Regulator Trust In the landscape of clinical research trials, trust plays a pivotal role in ensuring the integrity of the process and the reliability of outcomes. This tutorial guide aims to present a series of case studies focusing on journal policies and preprints, demonstrating their…

Read More “Case Studies: Journal Policies & Preprints That Strengthened Public and Regulator Trust” »

Training Clinical, Regulatory and Medical Teams on Journal Policies & Preprints Training Clinical, Regulatory and Medical Teams on Journal Policies & Preprints Introduction to Journal Policies and Preprints in Clinical Trials The landscape of clinical trials is continually evolving, requiring clinical, regulatory, and medical affairs professionals to stay informed about the latest in journal policies…

Read More “Training Clinical, Regulatory and Medical Teams on Journal Policies & Preprints” »